Literature DB >> 26202180

Does chronic hypertension prevent cancer progression?

Masaki Mogi1, Masatsugu Horiuchi1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26202180     DOI： 10.1038/hr.2015.87

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  10 in total

Review 1.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy.

Authors:  Michael F O'Rourke; Michel E Safar
Journal:  Hypertension       Date:  2005-05-23       Impact factor: 10.190

Review 2.  Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature.

Authors:  Giuseppe Lombardi; Fable Zustovich; Patrizia Farina; Pasquale Fiduccia; Alessandro Della Puppa; Valentina Polo; Roberta Bertorelle; Marina P Gardiman; Alberto Banzato; Pietro Ciccarino; Luca Denaro; Vittorina Zagonel
Journal:  Anticancer Drugs       Date:  2013-01       Impact factor: 2.248

3.  Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats.

Authors:  Subrina Jesmin; Yuichi Hattori; Hiroko Togashi; Ken-ichi Ueno; Mitsuhiro Yoshioka; Ichiro Sakuma
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

4.  Chronic arterial hypertension impedes glioma growth: a multiparametric MRI study in the rat.

Authors:  Annelise Letourneur; Simon Roussel; Myriam Bernaudin; Fabien Fillesoye; Jérôme Toutain; Eric T MacKenzie; Edwige Petit; Omar Touzani; Samuel Valable
Journal:  Hypertens Res       Date:  2015-06-18       Impact factor: 3.872

Review 5.  Angiogenesis in malignant glioma--a target for antitumor therapy?

Authors:  J Tuettenberg; C Friedel; P Vajkoczy
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-24       Impact factor: 6.312

Review 6.  Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review.

Authors:  Atticus H Hainsworth; Hugh S Markus
Journal:  J Cereb Blood Flow Metab       Date:  2008-08-13       Impact factor: 6.200

7.  Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression.

Authors:  He Wang; Bronia Olszewski; Wendy Rosebury; Dongkai Wang; Andrew Robertson; Joan A Keiser
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

8.  Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

Authors:  Ashwatha Narayana; Patrick Kelly; John Golfinos; Erik Parker; Glyn Johnson; Edmond Knopp; David Zagzag; Ingeborg Fischer; Shahzad Raza; Praveen Medabalmi; Patricia Eagan; Michael L Gruber
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

9.  Additive effects of mean blood pressure and bilateral notching in the second trimester on subsequent angiogenesis-related factors.

Authors:  Chikako Hirashima; Akihide Ohkuchi; Kayo Takahashi; Hirotada Suzuki; Yoshio Matsuda; Shigeki Matsubara; Mitsuaki Suzuki
Journal:  Hypertens Res       Date:  2013-08-15       Impact factor: 3.872

10.  Neurovascular protection of cilostazol in stroke-prone spontaneous hypertensive rats associated with angiogenesis and pericyte proliferation.

Authors:  Yoshio Omote; Kentaro Deguchi; Syoichiro Kono; Ning Liu; Wentao Liu; Tomoko Kurata; Toru Yamashita; Yoshio Ikeda; Koji Abe
Journal:  J Neurosci Res       Date:  2013-12-21       Impact factor: 4.164
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.